Overview

Trial of Forodesine in Patients With Relapsed B-cell Chronic Lymphocytic Leukemia

Status:
Terminated
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
To determine the dose and duration of treatment for the best overall response with Forodesine in relapsed B-cell chronic lymphocytic leukemia
Phase:
Phase 1
Details
Lead Sponsor:
Mundipharma Research Limited